Lucia Restano

Lucia Restano

Auto-generated profile, based on publicly available information

Lucia Restano

Department of Clinical Sciences and Community Health, Pediatric Dermatology Unit Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan Italy

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2000 in International Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
SMSilvano Menni
Silvano Menni
LRLucia Restano
Lucia Restano
RGRaffaele Gianotti
Raffaele Gianotti
DBDaniela Boccardi
Daniela Boccardi

31 August 2021 in Pediatric Dermatology
Verified
Journal Article
Open access
PDF file
RGRaffaele Gianotti
Raffaele Gianotti
LRLucia Restano
Lucia Restano
MCMario Cutrone
Mario Cutrone
CCCristiana Colonna
Cristiana Colonna
GFGiovanni Fellegara
Giovanni Fellegara
EBEmilio Berti
Emilio Berti
We observed ten children with a papular eruption with purpuric features during the SARS‐CoV‐2 pandemic in Northern Italy (May‐December 2020). Histological examination showed signs of SARS‐CoV‐2‐related dermatosis. Evidence of nucleocapsid viral proteins using SARS‐CoV‐2 (2019‐nCoV) nucleocapsid antibody revealed cuticular staining of the deep portion of the eccrine glands in all cases.

1 October 2006 in International Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
SCStefano Cambiaghi
Stefano Cambiaghi
CGChiara Galloni
Chiara Galloni
LRLucia Restano
Lucia Restano
RCRiccardo Cavalli
Riccardo Cavalli

9 October 2023 in JEADV Clinical Practice
Verified
Journal Article
Open access
LRLucia Restano
Lucia Restano
MBMarco Brusasco
Marco Brusasco
CCClaudio Cappadona
Claudio Cappadona
NMNicola A. Monzani
Nicola A. Monzani
RCRiccardo Cavalli
Riccardo Cavalli
Background: Scabies are a significant health issue for institutions and represent a health burden in children. Topical treatments such as permethrin 5% are usually effective but lately, a loss of efficacy has been observed.Objectives: To describe demographic data, topical treatment schemes (permethrin 5%; benzyl benzoate 25%) and outcomes in children with scabies over the past 2 years.Methods: We retrospectively evaluated records of children aged 0 to 14 years with scabies treated in our outpatient clinic from 1 January 2021 to 31 December 2022.Results: Two hundred and thirty‐one records were evaluated. Permethrin 5% (P5%) was used as first‐line treatment in 103 children with a success rate of 81.5%; benzyl benzoate 25% (BB25%) was successful in 94.3% of 123 patients. Three patients were lost for follow up and two received other therapies. Mean days of application using P5% increased from 4.1 to 6.8 in 2 years, whereas BB25% showed an opposite trend, from 10 days to 4.7. With the same days of application, the success rate with BB25% was higher (repeated cycle of 2 treatment days, 7 days apart [2 + 2]: 93.3% for BB25% vs. 82.9% for P5%; 3 + 3‐day regime: 91.9% for BB25% vs. 83% for P5%). Twenty‐three out of 26 patients who still had active scabies after the first cycle cleared with a second treatment cycle, with the same topical treatment, or with a different agent. Mild to moderate skin irritation was the only side effect observed (18.4%), more frequently associated with BB25% (81%).Conclusions: During the observational period, the use of permethrin decreased while regimen duration increased, probably due to a perceived lack of efficacy. Conversely the use of benzyl benzoate both as first‐line treatment and after permethrin failure increased, despite being more correlated to local inflammation. Both 2 + 2 and 3 + 3 regimes for P5% and BB25% may be considered as suitable first‐line treatment of scabies in children.

1 July 2009 in Pediatric Dermatology
Verified
Journal Article
Open access
PDF file
BRBarbara Riva
Barbara Riva
LRLucia Restano
Lucia Restano
CGCarlo Gelmetti
Carlo Gelmetti

1 January 1997 in Dermatology
Verified
Journal Article
Open access
PIP.H. Itin
P.H. Itin
SLStephan Lautenschlager
Stephan Lautenschlager
MGMichelle Goller
Michelle Goller
PCP. R. Cohen
P. R. Cohen
Madeleine DuvicMadeleine Duvic
Madeleine Duvic
MHM. Heenen
M. Heenen